Target intelligence / Profile preview

Rotavirus outer capsid protein VP4 and Rotavirus outer capsid protein VP7 (VP4, VP7)

Target
VP4, VP7
Molecular classification
Structural viral protein (VP4: spike-forming protein), Structural viral protein (VP7: glycoprotein, trimeric lattice), Other (not a host receptor, enzyme, transporter, or transcription factor; they are viral structural proteins crucial for infectivity and immune targeting)
01

Overview

Rotavirus outer capsid proteins VP4 and VP7 form the external structural layer of the virion and are essential for viral infectivity, cell attachment, entry, and immune recognition. VP4 assembles into spike-like projections responsible for binding to host cell receptors and mediating membrane penetration upon proteolytic cleavage. VP7 is a glycosylated, trimeric protein that forms a smooth outer lattice, stabilizing the virion and determining G serotype specificity. Both proteins are primary targets for host neutralizing antibodies, dictate immune protection and host specificity, and are the immunogens in all currently licensed rotavirus vaccines[1][3][5][6][8]. VP4 and VP7 are the key antigenic and structural molecules of the rotavirus outer capsid. They determine serotype-specific immunity, host range, and the infectivity of rotavirus. Both are considered therapeutic and diagnostic targets due to their roles in immune response and as neutralization antigens. The canonical names and structure (VP4 as spike protein, VP7 as glycoprotein layer) are standardized and directly supported by structural, immunological, and functional data[1][2][3][5][6][8].

Other names
VP4 protein (spike protein)VP7 protein (glycoprotein)Rotavirus spike protein (VP4)Rotavirus outer capsid glycoprotein (VP7)
02

Mechanism of action

Vaccines/antibodies binding VP7 or VP4 block conformational changes or receptor binding necessary for cell entry, neutralizing infectivity. Antibody-mediated neutralization (direct inhibition of membrane penetration or virus uncoating).

03

Biological functions

VP4: Viral cell binding (attachment to host cell)VP4: Membrane penetration (cell entry/penetration)VP4: HemagglutinationVP4: Determinant of host range and virulenceVP4: Mediates neutralization (target for antibodies and proteases)VP7: Formation of outer viral capsid layer (structural lattice)VP7: Determinant of G serotype specificityVP7: Neutralization antigen (target for protective antibodies)VP7: Cooperates in virion assembly and uncoating
04

Disease associations

Infection (causative of acute gastroenteritis, especially severe diarrheal disease in children)Immune system evasion (major antigens for serotype immunity and a target for vaccine development)
05

Safety considerations

Vaccine safety: risk of intussusception (rare but notable with rotavirus vaccines, not from the actual proteins but relevant for clinical targeting).Antigenic drift can reduce vaccine efficacy due to substantial antigenic diversity in VP4 and VP7 types (immune escape).No known intrinsic toxicity from VP4/VP7 as they are viral proteins, not endogenous targets.
06

Interacting drugs

Rotavirus vaccines (live attenuated: Rotarix, RotaTeq), which elicit immunity primarily via antibody response to VP4 and VP7.

1 more in the full profile.

07

Biomarkers

Serotype-specific serum antibodies to VP4 (P types) and VP7 (G types) used as correlates of vaccine-induced protection and for rotavirus strain typing in diagnostics.VP4/VP7 antigen detection in stool samples is diagnostic for rotavirus infection.

Beyond the preview

Go deeper on Rotavirus outer capsid protein VP4 and Rotavirus outer capsid protein VP7 (VP4, VP7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rotavirus outer capsid protein VP4 and Rotavirus outer capsid protein VP7 (VP4, VP7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call